Follow
Marco Marzioni
Title
Cited by
Cited by
Year
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ...
Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016
10582016
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
4642017
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
4622010
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ...
Liver International 31 (9), 1285-1297, 2011
4562011
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
4412018
Wnt–β-catenin signalling in liver development, health and disease
MJ Perugorria, P Olaizola, I Labiano, A Esparza-Baquer, M Marzioni, ...
Nature reviews Gastroenterology & hepatology 16 (2), 121-136, 2019
4072019
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver
D Alvaro, MG Mancino, S Glaser, E Gaudio, M Marzioni, H Francis, ...
Gastroenterology 132 (1), 415-431, 2007
3352007
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on …
G Svegliati-Baroni, C Candelaresi, S Saccomanno, G Ferretti, T Bachetti, ...
The American journal of pathology 169 (3), 846-860, 2006
3232006
Ductular reaction in liver diseases: pathological mechanisms and translational significances
K Sato, M Marzioni, F Meng, H Francis, S Glaser, G Alpini
Hepatology 69 (1), 420-430, 2019
3212019
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 8019, 2015
2962015
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
S De Minicis, C Rychlicki, L Agostinelli, S Saccomanno, C Candelaresi, ...
Hepatology 59 (5), 1738-1749, 2014
2802014
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical …
L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ...
Endoscopy 49 (06), 588-608, 2017
2672017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
A Arbelaiz, M Azkargorta, M Krawczyk, A Santos‐Laso, A Lapitz, ...
Hepatology 66 (4), 1125-1143, 2017
2662017
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism
E Gaudio, B Barbaro, D Alvaro, S Glaser, H Francis, Y Ueno, ...
Gastroenterology 130 (4), 1270-1282, 2006
2502006
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
A Di Sario, E Bendia, GS Baroni, F Ridolfi, A Casini, E Ceni, ...
Journal of hepatology 37 (5), 584-591, 2002
1902002
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell‐to‐cell interaction and transition
G Svegliati‐Baroni, S De Minicis, M Marzioni
Liver International 28 (8), 1052-1064, 2008
1772008
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ...
Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016
1702016
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between …
BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ...
Human molecular genetics 21 (23), 5209-5221, 2012
1692012
Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway
H Francis, S Glaser, S DeMorrow, E Gaudio, Y Ueno, J Venter, D Dostal, ...
American Journal of Physiology-Cell Physiology 295 (2), C499-C513, 2008
1542008
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha
G Alpini, L Baiocchi, S Glaser, Y Ueno, M Marzioni, H Francis, JL Phinizy, ...
Hepatology 35 (5), 1041-1052, 2002
1522002
The system can't perform the operation now. Try again later.
Articles 1–20